PKU Medicine’s first class of candidates for Pharm.D finishes thesis defense
Jun 19, 2020
Peking University, June 19, 2020: In May 2020, two candidates for Doctor of Pharmacy (Pharm.D) successfully finished their thesis defense, which marked a smooth development of our university’s pilot training of the first class of Pharm.Ds. This is the pilot project of Peking University’s comprehensive reform of deepening postgraduate education.
The two candidates have made fruitful achievements in both application and scientific research. In the research and administrative practice of drug therapy for Parkinson’s disease, under the supervision of Professor Zhai Suodi’s team, Dr. Yi Zhanmiao first set up the medication administration process for patients with Parkinson’s disease with the model of physician-pharmacist joint outpatient service. She built patient analysis and evaluation through evidence of evidence-based medicine and made appraisals of medication administration based on the framework of complicated interventions development and evaluation, so as to ensure the proper medication for patients with Parkinson’s disease. She has also published several research papers of practical significance of guidance, and won PKU’s academic innovation award.
Dr. Yi Zhanmiao finishes her doctoral thesis defense
Dr. Liu Zhiyan finishes her doctoral thesis defense online
There are now 10 doctoral supervisors and 17 doctoral candidates in applied pharmaceutics at Peking University. The Department of Pharmacy Administration and Clinical Pharmacy will further develop the interdisciplinary pilot training of applied Pharm.D, so as to train high-level talents in proper medication with good professional qualities and innovative spirits.
Written by: Lang Lang
Edited by: Huang Weijian
Source: PKU School of Pharmaceutical Sciences
